Defunct Company
Total Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
801
NCT04390477
Study to Evaluate the Effect of a Probiotic in COVID-19
Phase: N/A
Role: Lead Sponsor
Start: May 4, 2020
Completion: Apr 30, 2021
NCT05599607
Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata
Start: Mar 8, 2021
Completion: Dec 30, 2021
NCT05352724
Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise
Start: Oct 20, 2022
Completion: Apr 24, 2023
NCT07091955
Clinical Trial to Evaluate the Efficacy of a Probiotic Preparation in the Prevention of Upper Respiratory Tract Infections in Adults
Start: Oct 16, 2023
Completion: Feb 27, 2024
NCT06456125
Safety and Efficacy Of Amber Peripheral Liquid Embolic System
Start: Jun 12, 2024
Completion: Dec 31, 2026
NCT07154992
Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children
Start: Dec 17, 2024
Completion: Apr 30, 2027
NCT06815926
Clinical Trial to Evaluate the Effect of a Probiotic Product on Weight
Start: Feb 12, 2025
Completion: Jul 3, 2025
NCT07072273
A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic Dermatitis
Role: Collaborator
Start: Oct 31, 2025
Completion: Apr 30, 2026